DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 226 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,961,519 | +74.9% | 1,622,310 | +53.0% | 0.31% | +79.8% |
| Q2 2023 | $13,696,466 | +25.6% | 1,060,098 | -4.7% | 0.17% | +13.1% |
| Q1 2023 | $10,907,219 | -11.9% | 1,111,847 | -4.4% | 0.15% | -17.3% |
| Q4 2022 | $12,376,320 | +64.5% | 1,163,188 | +61.4% | 0.18% | +62.3% |
| Q3 2022 | $7,523,000 | +46.3% | 720,576 | +51.9% | 0.11% | +81.0% |
| Q1 2022 | $5,142,000 | -24.4% | 474,327 | -1.9% | 0.06% | -8.7% |
| Q4 2021 | $6,802,000 | -56.2% | 483,439 | -40.3% | 0.07% | -62.5% |
| Q3 2021 | $15,545,000 | +431.8% | 809,230 | +432.7% | 0.18% | +93.7% |
| Q1 2016 | $2,923,000 | -72.1% | 151,921 | -76.6% | 0.10% | -73.1% |
| Q4 2015 | $10,470,000 | -6.5% | 650,117 | +42.5% | 0.35% | -12.6% |
| Q3 2015 | $11,197,000 | +175.9% | 456,256 | +163.4% | 0.40% | +188.6% |
| Q2 2015 | $4,058,000 | -40.4% | 173,224 | -42.9% | 0.14% | -40.7% |
| Q1 2015 | $6,804,000 | – | 303,338 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,782,610 | $25,733,000 | 1.15% |
| Avidity Partners Management LP | 4,000,000 | $17,800,000 | 0.58% |
| PFM Health Sciences, LP | 2,936,990 | $13,070,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 925,534 | $4,119,000 | 0.34% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,470,000 | $6,542,000 | 0.22% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $545,000 | 0.21% |
| Rock Springs Capital Management LP | 1,649,420 | $7,340,000 | 0.16% |
| FEDERATED HERMES, INC. | 11,946,800 | $53,163,000 | 0.11% |
| Virtus ETF Advisers LLC | 57,062 | $254,000 | 0.10% |
| GABLES CAPITAL MANAGEMENT INC. | 31,225 | $139,000 | 0.08% |